Based on these reports, we used an HFD-induced rat model of hepatic steatosis to implement caloric restriction as a lifestyle modification and resveratrol as a drug therapy for lipid metabolism and study whether both forms of treatment act through SIRT1-mediated autophagy induction. Here, SIRT1 is linked to fatty liver disease.